Association of a 20-lncRNA signature with mutation load of colon adenocarcinoma and immune microenvironment

Y Lin, Q Li, Z Liu, R Liang, J Ye, Z He, X Gao, J Zhang… - 2022 - researchsquare.com
Purpose Tumor mutation burden (TMB) is an emerging biomarker for predicting immune
checkpoint inhibitors (ICI). However, the role of TMB associated with long non-coding RNAs …
相关文章

Association of a 20-lncRNA signature with mutation load of colon adenocarcinoma and immune microenvironment

Y Lin, Q Li, Z Liu, R Liang, J Ye, Z He, X Gao, J Zhang… - 2022 - europepmc.org
Purpose: Tumor mutation burden (TMB) is an emerging biomarker for predicting immune
checkpoint inhibitors (ICI). However, the role of TMB associated with long non-coding RNAs …